The Waterpipe Disconnect: Why Hookah Escaped the Tobacco Control Net

A single session of waterpipe smoking—sharing a hookah at a lounge with friends, a practice common among young adults in the Middle East, South Asia, and increasingly in Western countries—delivers the smoke equivalent of approximately 100 cigarettes, based on the volume of smoke inhaled. The smoke contains the same carcinogens, toxicants, and particulate matter as cigarette smoke, at concentrations that are often higher because of the charcoal used to heat the tobacco. The cardiovascular effects are immediate and significant: a single waterpipe session increases heart rate, blood pressure, and arterial stiffness to levels comparable to or exceeding those produced by cigarette smoking. The long-term health effects are consistent with the acute toxicology: waterpipe smoking is associated with lung cancer, respiratory disease, cardiovascular disease, and low birth weight. And yet waterpipe tobacco has largely escaped the regulatory attention that has been directed at cigarettes and, more recently, at vaping. The waterpipe disconnect—the gap between the harm caused by the product and the regulatory response—is one of the most striking regulatory failures in the nicotine landscape.

The cultural framing of waterpipe smoking is a significant factor in the regulatory gap. In the Middle East and South Asia, where waterpipe use has deep cultural roots, the practice is embedded in traditions of hospitality, social gathering, and intergenerational transmission. The cultural embeddedness makes waterpipe regulation politically sensitive in ways that cigarette regulation is not—governments that are willing to tax cigarettes aggressively may be reluctant to regulate a practice that is viewed as part of cultural heritage. In Western countries, where waterpipe use has grown among young adults since the 1990s, the practice is framed as a social, occasional activity rather than a daily addiction—a framing that is fostered by the industry's marketing (hookah lounges as upscale social venues, flavored shisha as a gourmet experience) and that masks the substantial toxicant exposure of even occasional use. The waterpipe smoker who visits a hookah lounge once a week, consuming the equivalent of 100 cigarettes' worth of smoke in a single session, is exposing themselves to more combustion products than a daily light cigarette smoker. The cultural framing—'it's just hookah, it's not like cigarettes'—is not just misleading. It is lethally inaccurate.

The regulatory treatment of waterpipe tobacco is inconsistent and inadequate across jurisdictions. In the United States, waterpipe tobacco is regulated as a 'deemed' tobacco product under the FDA's authority, subject to the same PMTA requirements, flavor restrictions, and marketing limitations as other tobacco products. But enforcement is minimal—hookah lounges operate in a regulatory gray zone, indoor smoking restrictions are often circumvented through 'sampling' exemptions or inadequate enforcement, and the flavored shisha that is central to the waterpipe experience continues to be sold despite the broader flavor restrictions that apply to cigarettes and, in some jurisdictions, vaping products. In the Middle East, waterpipe regulation varies from comprehensive (in some Gulf states, where indoor waterpipe smoking has been restricted) to nonexistent (in countries where the waterpipe industry has successfully resisted regulation through cultural and economic arguments). The global regulatory framework for waterpipe tobacco is fragmented, inconsistent, and—in most jurisdictions—significantly less restrictive than the framework for cigarettes, despite the comparable health risks.

The industry dimension of the waterpipe disconnect is revealing. The waterpipe industry—from the manufacturers of shisha tobacco (Al Fakher, Starbuzz, Fumari) to the operators of hookah lounges to the manufacturers of waterpipe hardware—has positioned itself as distinct from the cigarette industry, emphasizing the social and cultural dimensions of waterpipe use and avoiding the imagery of addiction and mortality that is associated with cigarettes. The industry's strategy has been effective: waterpipe tobacco is subject to lower taxes, fewer marketing restrictions, and less public scrutiny than cigarettes in most jurisdictions. The strategy is not fundamentally different from the cigarette industry's historical strategy of positioning smoking as a lifestyle choice rather than a health risk—but the waterpipe industry has been more successful, in part because public health attention has been focused on the larger and more lethal cigarette market. The waterpipe industry has benefited from being too small to be a priority but too culturally embedded to be ignored.

The public health response to waterpipe smoking has been inadequate on multiple levels. The evidence base on waterpipe health effects, while substantial, is smaller and less methodologically robust than the evidence base on cigarettes—a reflection of research funding priorities that have focused on the larger cigarette epidemic. The surveillance systems that track smoking prevalence—the national surveys that provide the data for public health planning—often measure waterpipe use poorly or not at all, particularly in countries where the practice is most prevalent. The cessation support infrastructure for waterpipe users is essentially nonexistent—there are no evidence-based waterpipe cessation protocols, no dedicated quitlines, no pharmacological interventions that have been specifically tested for waterpipe cessation. The public health community has not ignored waterpipe—the WHO has published reports and guidelines, and waterpipe is included in the FCTC framework—but the response has been proportional to the visibility of the problem rather than its scale. The waterpipe disconnect is a failure of attention, not of evidence.

Addressing the waterpipe disconnect requires regulatory measures that close the gap between waterpipe and cigarette regulation: indoor smoking bans that cover hookah lounges without exemptions; flavor restrictions that treat waterpipe tobacco the same as other flavored tobacco products; taxation that reflects the health costs of waterpipe smoking; and health warnings that communicate the specific risks of waterpipe use (including the '100 cigarettes per session' equivalence, which is a powerful communication tool). It also requires research investment in waterpipe-specific epidemiology, surveillance, and cessation. And it requires engagement with the cultural dimension of waterpipe smoking—acknowledging the cultural significance of the practice while communicating its health risks, without the cultural insensitivity that would make the communication counterproductive. The waterpipe disconnect is not an argument for less regulation of cigarettes. It's an argument for more regulation of waterpipe—an argument that public health has been making for decades, with limited success, because the political and cultural obstacles are substantial.

Shareable insight: A single hookah session exposes the user to the smoke equivalent of approximately 100 cigarettes. And yet waterpipe tobacco is subject to less regulation, lower taxes, and weaker health warnings than cigarettes in most jurisdictions. The waterpipe disconnect—the gap between harm and regulatory response—is one of the most striking failures of global tobacco control.